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INTRODUCTION
Abortion is a common event in pregnancy and
about 80% of spontaneous abortions occur in the
first trimester of pregnancy. The causes of abor-
tion, such as genetics, anatomy, infection, endo-
crine disorders, autoimmune factors, and external
environmental exposures such as cigarette smoke,
alcohol, and toxic substances.1-4
The presence of antithyroid antibodies in the first
trimester of pregnancy was significantly associated
with an increased incidence of abortion. Women with
antithyroid antibodies may have normal thyroid
gland function, but at greater risk for the occurrence
of spontaneous abortion. Some studies indicate that
women with recurrent miscarriage had higher levels
of antithyroid antibodies higher than women who
did not have recurrent miscarriage.
Abstract
Objective: To assess the relationship between the incidence of
threatened abortion with serum levels of TPO antibodies.
Methods: This was cross-sectional study involving subjects 40 cases
and 40 controls. The study was conducted September 2012 to No-
vember 2012. The difference in the levels of thyroid peroxidase an-
tibody was tested by Mann-Whitney test.
Result: In this study, hypothyroidism was found only in the abortion
group, as many as 6 subjects (15%) and subclinical hypothyroidism
was more prevalent in threatened abortion group, found in 2 people
(5%), compared to normal pregnant group, found in only 1 person
(2.5%). This study revealed a significant difference in the mean le-
vels of TPO antibodies in the threatened abortion and normal preg-
nancy group. The mean levels of TPO antibodies in threatened abor-
tion group was 91.76 ± 133.18 IU/ml with the lowest level of 14.41
IU/ml and the highest levels of 534.47 IU/ml while in the normal
pregnancy group found an average 12.97 ± 3.91 IU/ml with the lo-
west value 2.02 IU/ml and the highest value of 20.78 IU/ml. In this
study, subjects with TPO antibody levels ≥ 125 IU/ml, all of them ex-
perienced threatened abortion (n = 7) and found the risk of miscar-
riage by 2.212-fold compared with subjects with TPO levels < 125
IU/ml.
Conclusion: There are differences in the levels of TPO antibodies in
patients with threatened abortion and in normal pregnancies, with
average levels of TPO antibodies in imminent abortion group is
higher than normal pregnancy group. There is a relationship bet-
ween TPO antibody levels ≥ 125 IU/ml with the incidence of threat-
ened abortion, with the risk of threatened abortion increasing 2.212
times.
[Indones J Obstet Gynecol 2013; 1-3: 134-8]
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Abstrak
Tujuan: Mengetahui hubungan antara kejadian abortus iminens de-
ngan kadar TPO antibody dalam serum.
Metode: Penelitian ini menggunakan rancangan penelitian cross sec-
tional/belah lintang dengan subjek 40 kasus dan 40 kontrol. Penelitian
dimulai September 2012 sampai November 2012. Perbedaan kadar
thyroid peroxidase antibody serum dan data lain yang bersifat nu-
meric diuji dengan uji Mann-Whitney.
Hasil: Dalam penelitian ini hipotiroid hanya ditemukan pada kelom-
pok abortus yaitu 6 orang (15%) demikian halnya dengan hipotiroid
subklinis lebih banyak ditemukan pada kelompok abortus yaitu 2
orang (5%) dibandingkan kelompok hamil normal hanya ditemukan
1 orang (2,5%). Pada penelitian ini ditemukan perbedaan bermakna
rerata kadar TPO antibody pada kelompok abortus iminens dan
kelompok hamil normal. Rerata kadar TPO antibody pada kelompok
threatened abortion 91,76 ± 133,18 IU/ml dengan kadar terendah
14,41 IU/ml dan kadar tertinggi 534,47 IU/ml sedangkan pada kelom-
pok hamil normal ditemukan rerata 12,97 ± 3,91 IU/ml dengan nilai
terendah 2,02 IU/ml dan nilai tertinggi 20,78 IU/ml. Dalam penelitian
ini subjek dengan kadar TPO antibodi ≥ 125 IU/ml kesemuanya me-
ngalami abortus iminens (n = 7) dan didapatkan risiko terjadinya
abortus sebesar 2,212 kali lipat dibandingkan dengan subjek dengan
kadar TPO < 125 IU/ml.
Kesimpulan: Terdapat perbedaan kadar TPO antibody pada pasien
dengan abortus iminens dibandingkan pada kehamilan normal, de-
ngan rerata kadar TPO antibody pada kelompok abortus iminens le-
bih tinggi dibandingkan kelompok hamil normal.
Terdapat hubungan antara kadar TPO antibody ≥ 125 IU/ml dengan
kejadian abortus iminens, dengan risiko sebesar 2,212 kali untuk ter-
jadinya threatened abortion.
[Maj Obstet Ginekol Indones 2013; 1-3: 134-8]
Kata kunci: abortus iminens, thyroid peroxidase antibodi (TPO anti-
bodi)
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Thyroid autoimmune disorder characterized by
the presence of antithyroid antibodies, notably thy-
roid peroxidase (TPO) and thyroglobulin antibody
(TG) antibodies. Marai and Lejeune in 1988 sug-
gested that TPO antibodies are the most common
antibodies found in patients with recurrent miscar-
riage.5-7
This study analyze the differences in levels of
TPO antibodies in patients with threatened abor-
tion with patients with normal pregnancies, and
the relationship between TPO antibody levels with
the incidence of threatened abortion. The objective
of this study was to assess the relationship bet-
ween the incidence of threatened abortion with
TPO antibody levels in serum.
In early pregnancy there is an increase in renal
blood flow and filtration glomelurus resulting in in-
creased plasma iodide clearance. This has led to a
decrease in plasma concentrations of iodide and in-
creasing the iodide body’s needs. Thyroid hormone
(TH) is transported in the serum and attached to
three proteins with non-covalent bound namely T4
binding globulin (thyroxine binding globulin/TBG),
albumin, and transtiretin (formerly known as pre-
albumin), about two-thirds of the normal serum T4
carried by TBG.8-11
In pregnancy, changes in total thyroid hormone
levels is a direct consequence of the apparent in-
crease in serum TBG, total T4 and T3 levels in-
creased significantly during the first half of preg-
nancy. Serum T4 levels increased significantly be-
tween 6 to 12 weeks, further progress will be
slowly, and become stable around the mid-gesta-
tion, whereas the increase in serums T3 occurred
more progressive. T3 and T4 total reaches plateau
at 20 weeks of gestation and remains until term
pregnant. Because of the increased affinity of TBG
for T4 up to 20-fold when compared with T3, T4
levels change following the changes in TBG occurs
rapidly.10,11
The process of forming the thyroid hormones is
started by pumping process/active iodide trapping
that pumped into the cells and thyroid glands fol-
licle that stimulated by TSH and hCG. The concen-
tration of free iodide is concentrated in the glan-
dular cells up to 30-40 times. Endoplasmic reticu-
lum and Golgi apparatus synthesize and secrete the
glycoprotein molecule called thyroglobulin into the
follicle glands. Each molecule thyroglobulin will in-
tegrate with iodide to form thyroid hormone na-
mely thyroid hormone thyroxine (T4) and triio-
dothyronine (T3). The synthesized thyroid hor-
mone then stored in the thyroid gland.
The initial stage of the formation of thyroid hor-
mones is the iodide ion alteration to form oxidized
iodine (oxidation of iodide ion). The thyroid per-
oxidase enzyme catalyzes this process. This enzy-
me is located in the apical membrane of cells
whose function is to placed oxidized iodine in the
cell, right on the place that thyroglobulin molecules
released from the Golgi apparatus and through the
cell membrane into the storage area. If the peroxi-
dase system was hampered, it will decrease the
speed of formation of thyroid hormone. This inhi-
bition may occur because the effect of thyroid per-
oxidase antibodies.12-14
Several studies suggest that primary hypothy-
roidism is associated with antithyroid antibodies
that affect fertility and spontaneous abortion. Hy-
pothyroid condition characterized by a TSH ≥ 6
mIU/l and free T4 (FT4) ≤ 0.8 ng/dl. Pregnant wo-
men with hypothyroidism also have an increased
risk of obstetric complications such as intra-uterine
fetal death, gestational hypertension, placental so-
lutio, and unfavorable perinatal conditions.15
Subclinical hypothyroidism occurs more fre-
quently in pregnant women with positive antithy-
roid antibodies with serum TSH levels were normal
before conception. Subclinical hypothyroidism is
characterized by a TSH ≥ 6 mIU/l and FT4 levels
within the normal range (0.8 - 2.2ng/dl). Klein et
al conducted a retrospective study on a data bank
of serum from 2000 pregnant women with gesta-
tional age 15-18 weeks and found that 2.5% of all
pregnant women had TSH concentrations above
normal, and one-tenth develop hypothyroid. They
also found that pregnant women with positive an-
tithyroid antibodies had a 5-fold risk for the occur-
rence of subclinical hypothyroidism.14-17
Stagnaro-Green et al in 1990 and Glinoer in
1991 were the first to report a strong correlation
between positive antithyroid antibodies and the
risk of spontaneous abortion in euthyroid women.
The relative risk of abortion is 2-4 times greater in
women with positive antithyroid antibodies.
A thyroid peroxidase antibody is one of the spe-
cific serological marker for diagnosing autoimmu-
ne thyroid disease. Thyroid peroxidase antibodies
produced by lymphocytes B through T-cell depend-
ent mechanism. In recent years, it is known that
thyroid peroxidase antibodies known as an epitope
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which is highly dependent of the three-dimensional
structure of the enzyme molecule TPO. Thyroid pe-
roxidase antibodies immunodominant section are
limited by two surfaces containing different but ad-
jacent epitope. In 1989, Ruf and Carayons localize
places on human antigen-TPO and TPO antibodies
discovered four domains that is interact with do-
main A through D of the enzyme TPO. However, in
future studies only two domains dominant antigen
which have a bond that is domain A and B. Through
the action of the enzyme is inhibited by TPO anti-
bodies. This suggests that these two parts form the
immunodominant regions of human-TPO.18
Wakim et al in 1994 in his study suggested that
thyrotropin and thyroid hormone receptor found
in ovarian granulose cells and the hormones T4 and
T3 in the follicle. T4 increases gonadotropin action
on the luteinizing process so that stimulates the se-
cretion of progestin. Deficiency of thyroid hormone
at the level of the ovary will affect gonadal dysfunc-
tion. Formation of thyroid hormone needed for the
role of the TPO enzyme for oxidation iodide ion
and iodide thyroglobulin organofication with oxi-
dized iodide to form the thyroxine hormone (T4)
and triiodothyronine (T3). TPO antibodies, through
it binding with domains A and B in the TPO en-
zyme, will inhibit the action of this enzyme in the
process of oxidation and organification that re-
sulted in adecrease serum concentrations of thy-
roid hormones.18,19
There are differences in the levels of TPO anti-
bodies in patients with threatened abortion than
in normal pregnancies.
There is a relationship between high levels of
maternal antibodies TPO high (≥ 125 IU/ml) and
the incidence of threatened abortion
METHODS
This study is a cross sectional study, held in Obste-
trics and Gynecology Department at RSUP Dr. Ka-
riadi Semarang, Puskesmas Halmahera and Pus-
kesmas Ngesrep Semarang. The examination of
TPO antibodi was held in Laboratorium GAKI-
Medical Faculty of Diponegoro University from
September 2012 until November 2012. Subject of
this study was women diagnosed with threatened
abortion on 8-20 weeks of gestational age.
Inclusion criterias were women ≤ 35 y.o diag-
nosed with threatened abortion on 8-20 weeks of
gestational age, and noticed fetal plate, normoten-
sion, normoweight, no previous abortion, no sis-
temic infection no abdominal trauma, agreed for
blood examination and signing the informed con-
sent form. The control group consist of patients
with normal pregnancy, meeting inclusion crite-
rias, willing to be the subject of study and signing
the informed consent form.
Patient meeting the inclusion criteria received
counseling and a questionnaire. The blood sample
was taken from v. Mediana cubiti, and placed in
reaction glass without EDTA, then the blood mus
be centrifuged immidiately to separate the serum.
After sentrifuged, thyroid peroxidase antibodies
will be in a stable condition in the serum for up to
7 days in the refrigerator (2-8°C) or 6 months with
a temperature of -20°C. Obtained blood samples
will be examined to measure serum levels of TPO
antibodies by enzyme-linked immunosorbent tech-
nique assay (ELISA) with a unit of measure IU/ml.
The difference in the levels of thyroid peroxi-
dase antibody was tested by Mann-Whitney test.
RESULT
The study was conducted in the RSUP Dr. Kariadi,
RSUD Tugurejo, Puskesmas Ngesrep and Puskes-
mas Halmahera Semarang, from September 2012
to October 2012, involved 80 subjects, that is preg-
nant women 8 to 20 weeks who fullfiled the study
criteria. There are 22 subjects obtained from RS Dr.
Kariadi Semarang, 24 subjects from RSUD Tugu-
rejo, 15 subjects from Puskesmas Halmahera, and
19 subjects from Puskesmas Ngesrep. Based on the
history and examination performed, the study sub-
jects were divided into two groups of 40 pregnant
women accompanied by signs of threatened abor-
tion and 40 normal pregnant women as a control
group.
In threatened abortion group, the mean levels of
antibodi TPO is 91.76 ± 133.18 IU/ml, with the
lowest level is 14.41 IU/ml and the highest level is
534.47 IU/ml, with a median of 33.73 IU/ml. In
normal pregnant group, the mean levels of TPO an-
tibodies is 12.97 ± 3.91 IU/ml, with the lowest le-
vels is 2.02 IU/ml and the highest level is 20.78
IU/ml, with a median of 13.23 IU/ml.
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Table 1. Antibody TPO Level in Threatened Abortion and
Normal Pregnancy Group.
Diagnose
Variable Threatened
Abortion n=40
Normal
Pregnancy n=40
p
Rerata (SB) Rerata (SB)
TPO an-
tibody
91.76 (133.18) 12.97 (3.91) 0.000#
#: Mann-Whitney test
Table 2. The Relationship of TPO Antibody Levels with
the Incidence of Threatened Abortion
TPO antibody
level category
Threatened abortion
Yes No
High (≥ 125 IU/ml) (n=7) 7 (100%) 0 (0%)
Normal (< 125 IU/ml) (n=73) 33 (45.2%) 40 (54.8%)
p = 0.006 (Chi-square test); RP = 2.212 (95% CI = 1.718 - 2.848)
Aziz et al 2002 found that TPO antibody levels
≥ 125 IU/ml had a 4-fold risk for the occurrence of
abortion in pregnancy. With these limits, we as-
sessed the relationship between high levels of TPO
antibodies with threatened abortion. From the data
in Table 5, by using the limitation of TPO antibody
levels 125 IU/ml, showed a significant association
between high levels of TPO antibodies with the in-
cidence of threatened abortion, with TPO antibody
levels ≥ 125 IU/ml had a 2.212-fold risk for the
occurrence of threatened abortion (prevalence ra-
tio/RP = 2.212; p = 0.006)
DISCUSSION
The incidence of miscarriage increases with mater-
nal age. In women aged 20-24 years the incidence
of abortion is about 12%, which was later increa-
sed to 26% in the age group > 35 years. This is
presumably related to implantation failure due to
poor quality embryos, chromosomal abnormalities
associated with age or because of declining endo-
metrium receptability. In this study, the subjects
aged ≤ 35 years. The mean age of mothers in both
groups did not differ, nor did her husband with a
mean age in the two groups. Most subjects were
within the reproductive age (75%). The mean ges-
tational age in normal pregnancy group was elder
than in the threatened abortion group.
Pregnant women with hypothyroidism have an
increased risk of miscarriage, intra-uterine fetal
death, gestational hypertension, placental solutio,
and unfavorable perinatal conditions. Klein et al
found that at the age of 15-18 weeks of pregnancy
2.5% had TSH concentrations above normal, and
the one-tenth developed hypothyroid. This study
found hypothyroid only in abortion group is 6 peo-
ple (15%) case with subclinical hypothyroidism
are more common in abortion group is 2 people
(5%) compared to normal pregnant group that
found only 1 person (2.5%). This is consistent with
research by Glinoer et al that states pregnant wo-
men with subclinical hypothyroidism and hypothy-
roidism had 2.5 times the risk for the occurrence
of abortion.
Thyroid peroxidase (TPO) antibody is a specific
serological marker for diagnosing autoimmune
thyroid disease. Wakim et al found thyrotropin and
thyroid hormone receptor in ovarian granulose
cells and the hormones T4 and T3 in the follicle. T4
increases gonadotropin action on the luteinizing
process so that stimulates the secretion of pro-
gestin. Deficiency of thyroid hormones on ovarian
levels will impact on low progestin hormone secre-
tion. The low levels of this hormone in the first tri-
mester of pregnancy will increase the risk of abor-
tus. This study found significant differences in the
mean levels of TPO antibodies in the threatened
abortion and normal pregnancy group. The mean
levels of TPO antibodies in abortion group immi-
nens is 133.18 ± 91.76 IU/ml with the lowest level
is 14.41 IU/ml and the highest levels is 534.47
IU/ml while in the normal pregnancy group found
an average is 12.97 ± 3.91 IU/ml with the lowest
value is 2.02 IU/ml and the highest value is 20.78
IU/ml. This is consistent with the first hypothesis
that there are different levels of TPO antibodies in
threatened abortion group than in the normal
pregnancy group with higher average in the group
of threatened abortion.
The second hypothesis is the relationship bet-
ween high antibody TPO levels (≥ 125 IU/ml) and
the incidence of threatened abortion. Aziz et al
found the TPO antibody levels ≥ 125 IU/ml had 4
times the risk of abortion, and the mean levels of
TPO antibodies in abortion group was higher than
normal pregnant group. This is correspond with
the second hypothesis, in this study, subjects with
higher levels of TPO antibody ≥ 125 IU/ml, all of
which developed threatened abortion (n = 7) and
have the risk of miscarriage by 2.212-fold com-
pared with subjects with TPO levels < 125 IU/ml.
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T4 play an important role in the luteinizing proc-
ess that stimulates the secretion of progestin that
is needed to preserving pregnancy. In normal preg-
nancy there is sharp increase production of the T4
at the age of 6 to 12 weeks gestation, further pro-
gress will be slow, and be stable during mid-gesta-
tion, whereas T3 hormones increasing occur more
progressive. T3 and T4 total reaches plateau at 20
weeks of gestasion and persisted until term. Mo-
larity ratio of T3/T4 must be maintained so as not
to changed during pregnancy. Pregnant women
with positive TPO antibodies experience inhibition
the formation of hormon T4. Negro et al provide
levotiroksin (LT4) to pregnant women with posi-
tive TPO antibodies but with normal thyroid func-
tion and found the incidence of abortion and pre-
mature births is lower 3, 9 times compared to
those who did not receive therapy LT4. Therapy
LT4 after 12 weeks of gestation did not reduce the
risk of miscarriage and premature birth.
CONCLUSION
There is a significant difference in the levels of TPO
antibodies in patients with threatened abortion
and in normal pregnancies, with average levels of
TPO antibodies in abortion group imminens is
higher than in normal pregnant group. There is a
relationship between TPO antibody levels ≥ 125
IU/ml with the incidence of threatened abortion,
with the risk of threatened abortion increasing
2.212 times.
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